Overview Fundamentals API Earnings EOD API Sample Code Pricing

Ensysce Biosciences Inc (ENSC NASDAQ) stock market data APIs

$0.6688 -0.06(-8.2%) as of November 8, 2024
Price chart is built with Anychart

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company is developing PF614, a TAAP oxycodone prodrug candidate for the treatment of acute or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat for overdose protection against excessive oral ingestion, as well as an oral and inhalation drug product of nafamostat for use against coronaviral infections and other pulmonary diseases, such as cystic fibrosis. It is also developing PF614, an extended-release oxycodone-derivative that releases clinically effective oxycodone; PF329 for pain with abuse protection; PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for ADHD; and PF9001 to treat Opioid use disorder. The company was founded in 2003 and is based in La Jolla, California.

Ensysce Biosciences Inc Financial Data Overview

0.73
0.6688
-
0.75
0.6102
0.1412-2.06
10 887 K
14 914 K
1 438 K
0.639
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ENSC',
Type: 'Common Stock',
Name: 'Ensysce Biosciences Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00JFF4174',
ISIN: NULL,
CUSIP: NULL,
CIK: '1716947',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2018-02-26',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Ensysce Biosciences Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 1 438 K
  • EBITDA -24 221 944
  • Earnings Per Share -2.74
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Ensysce Biosciences Inc Earnings via APIs

  • Latest Release 2024-11-07
  • EPS/Forecast -0.29

Get Ensysce Biosciences Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com